Pricing & Access

Ozempic Cost Australia: Private Pricing, PBS Status and Supply Issues

Here’s how Ozempic pricing typically works in Australia—private price ranges per pen, PBS coverage rules for type 2 diabetes, what monthly costs look like at each dose, and how current supply affects access. Compare options like Wegovy, Rybelsus and Mounjaro before you choose.

Check your costs and options

Key takeaways on Ozempic cost in Australia

  • Typical private price: roughly $120–$180 per pen, but varies by pharmacy, location and supply.
  • PBS: available for eligible type 2 diabetes patients only (not for weight loss). If approved, you pay the PBS co-payment.
  • Monthly spend depends on dose: 0.5 mg or 1.0 mg weekly usually equals ~1 pen per month; 0.25 mg weekly lasts longer.
  • Shortages continue intermittently. Discuss timing, pharmacy ordering and approved alternatives with your prescriber.

Get personalised pricing guidance

Current private Ozempic price ranges

Private pricing for Ozempic (semaglutide) is set by individual pharmacies. Recent shopper reports and pharmacy boards suggest the following ballpark ranges:

  • Starter/0.25–0.5 mg pen: commonly ~$120–$170 per pen
  • 1.0 mg pen: commonly ~$130–$180 per pen

Why the range? Pharmacies negotiate different wholesale costs, adjust margins during shortages, and may price differently across metro vs regional locations. Some pharmacies also require pre-payment to order stock.

Ask us to estimate your local spend

PBS status: who qualifies and what you’ll pay

Ozempic is listed on the Pharmaceutical Benefits Scheme (PBS) for eligible adults with type 2 diabetes. Weight loss alone is not a PBS-approved use. Prescribers must meet PBS authority criteria and document the clinical need.

  • If you qualify, you pay the PBS co-payment (general or concession). The Government may update co-pay amounts each January.
  • Households who reach the PBS Safety Net threshold pay a reduced co-pay for the remainder of the calendar year.

If you are not eligible for PBS (for example, using semaglutide for weight management), you will pay private prices. Consider approved alternatives designed for weight management, such as Wegovy, and discuss suitability with your clinician.

Check PBS eligibility and prescription steps

Monthly cost examples by dose

Dosing and pen content determine how long a pen lasts. The figures below are practical rules of thumb. Your pharmacy’s instructions and your prescriber’s plan take priority.

  • 0.25 mg weekly (typical first 4 weeks): roughly 1 starter pen can last about 8 weeks.
  • 0.5 mg weekly: roughly 1 starter pen lasts about 4 weeks (≈1 pen/month).
  • 1.0 mg weekly: typically requires the 1.0 mg pen; about 1 pen lasts ~4 weeks (≈1 pen/month).

Using the private price range above, a typical monthly spend could be around $120–$180 at 0.5 mg or 1.0 mg weekly. During escalation, your monthly cost may fluctuate as your dose changes and pen type switches.

Get a dose-by-dose cost outline

Supply issues and how they affect price and access

Australia has experienced intermittent Ozempic shortages due to global demand. The TGA has periodically highlighted limited supply and advised prescribers to prioritise approved indications. This can lead to:

  • Waitlists at pharmacies, variable delivery dates and limited dispensing.
  • Private price differences across pharmacies and regions.
  • Switch discussions to approved alternatives where clinically suitable.

Stay with approved products and Australian pharmacies. Be cautious with online sellers or “compounded” or “research” semaglutide claims that are not TGA-approved. If your pharmacy cannot source Ozempic in time, ask your clinician about:

Compare availability near you

Ozempic vs Wegovy vs Rybelsus vs Mounjaro: cost snapshots

These medicines have different approved uses and coverage. Costs change with supply and pharmacy pricing, but this is the general picture:

  • Ozempic (semaglutide injection): PBS for eligible type 2 diabetes; private typically ~$120–$180 per pen.
  • Wegovy (semaglutide injection for weight management): private pricing varies by dose; supply is staged and may be limited.
  • Rybelsus (oral semaglutide): private price varies; check local pharmacy quotes.
  • Mounjaro (tirzepatide injection): PBS for eligible type 2 diabetes; private pricing is typically higher than Ozempic when not PBS-covered.

Always confirm with your prescriber which product is appropriate for your condition and then obtain current pharmacy quotes in your area.

Ways to keep costs down (legitimately)

  • Review PBS eligibility with your prescriber if you have type 2 diabetes and meet criteria.
  • Track your PBS Safety Net status if you use multiple scripts in your household.
  • Ask pharmacies for current stock and quotes—prices and supply can vary locally.
  • Avoid unapproved or overseas online sellers. Sticking with TGA-approved supply helps reduce risk.
  • Plan refills ahead of time, especially before holidays, to avoid last‑minute shortages.

Request a personalised cost plan

Frequently asked questions

How much does Ozempic cost privately in Australia?

Expect roughly $120–$180 per pen, depending on pharmacy, location and supply. At 0.5 mg or 1.0 mg weekly, that typically works out to about one pen per month.

Is Ozempic covered by the PBS?

Yes, for eligible adults with type 2 diabetes under PBS criteria. Weight loss alone isn’t PBS-covered. If approved, you pay the PBS co-payment (general or concession), which can change each January.

What if my pharmacy is out of stock?

Join a waitlist, ask about delivery schedules, and discuss approved alternatives with your prescriber such as Wegovy, Rybelsus or Mounjaro. Avoid unapproved or online “semaglutide” offers.

How many pens do I need per month?

As a rough guide: 0.25 mg weekly ~ one pen for ~8 weeks; 0.5 mg weekly ~ one pen/month; 1.0 mg weekly ~ one pen/month (using the 1.0 mg pen). Your plan may differ; follow your prescription and pharmacist instructions.

What’s the difference between Ozempic and Wegovy?

Both contain semaglutide but are branded and indicated differently. Ozempic is indicated for type 2 diabetes (PBS-eligible for those who qualify). Wegovy is indicated for weight management. Dosing and supply differ. See Ozempic vs Wegovy.

Are there other approved GLP‑1 options?

Yes. Rybelsus (oral semaglutide) and Mounjaro (tirzepatide, a dual‑agonist) are approved. Coverage, indications and costs differ.

Still unsure? Get help with pricing

Get help estimating your Ozempic costs

Tell us where you’re based, your intended dose and whether you might qualify for PBS. We’ll outline likely monthly costs and point you to relevant next steps. We don’t sell medication and we don’t replace medical advice.

We use your details only to respond to your request. For medical decisions, please consult a registered Australian prescriber.

Final takeaway

In Australia, Ozempic’s private price is usually around $120–$180 per pen, while PBS co-pay applies only for eligible type 2 diabetes. Monthly spend depends mostly on your weekly dose and which pen you receive. Ongoing supply constraints mean availability and price can vary—plan ahead and discuss approved alternatives if needed.

Get a tailored cost outline